Project Experiences
The Tobacco Industry Interference Index (TII Index), published by RUKKI (Ruang Kebijakan Kesehatan Indonesia), is a tool to assess the degree of tobacco industry interference in the policymaking process. The TII Index provides a framework for identifying and analyzing the ways in which the tobacco industry interferes with tobacco control measures at the national level. The index covers seven areas of tobacco industry interference, the higher the score, the more interference occurs.
Summary of Key Findings – Indonesia Tobacco Industry Interference Index 2023
- Industry Participation in Policy Development
- The government is preparing a Tobacco Products Roadmap influenced by industry proposals.
- Multiple ministries support this roadmap, while revisions to PP 109/2012 face pushback.
- Ministries support Heated Tobacco Products (HTPs) with favorable policies.
- Corporate Social Responsibility (CSR) Activities
- Tobacco companies use CSR to enhance public image.
- Events often involve senior government officials.
- Benefits to the Tobacco Industry
- Government provided excise payment delays and blocked local regulations.
- Unnecessary Interaction
- High-level officials joined industry events.
- Ministry of Investment partners with tobacco companies.
- Transparency
- No procedure to disclose meetings with the industry.
- Lobbying activities remain hidden.
- Conflict of Interest
- Ex-officials hold positions in tobacco associations.
- Preventive Measures
- Only Ministry of Health has a code of conduct.
- No national effort for WHO FCTC implementation.
This study provides an in-depth analysis of the challenges faced in formulating and enforcing health regulations in Indonesia, with a specific focus on addictive substances. This book uncovers the complex tactics employed by the tobacco industry and its allies to weaken public health policies.
This book explores global regulations on novel nicotine and tobacco products, with a primary focus on electronic cigarettes. Its purpose is to provide comprehensive insights to support the development of national regulations that prioritize public health protection.
The document “Technical Guidelines for Tuberculosis with Comorbidities” was developed as a national guideline for all TB program implementers and comorbid disease programs, such as diabetes mellitus (DM), HIV, malnutrition, smoking, and other comorbidities.